DK97286A - Fremgangsmaade til fremstilling af gammaglobulin, der er egnet til intravenoes indgivelse - Google Patents

Fremgangsmaade til fremstilling af gammaglobulin, der er egnet til intravenoes indgivelse Download PDF

Info

Publication number
DK97286A
DK97286A DK97286A DK97286A DK97286A DK 97286 A DK97286 A DK 97286A DK 97286 A DK97286 A DK 97286A DK 97286 A DK97286 A DK 97286A DK 97286 A DK97286 A DK 97286A
Authority
DK
Denmark
Prior art keywords
concn
intravenoes
gammaglobulin
administration
procedure
Prior art date
Application number
DK97286A
Other languages
English (en)
Other versions
DK97286D0 (da
DK164023B (da
DK164023C (da
Inventor
Juergen-Dietrich Fried Fiechtl
Bernhard Kerner
Juergen Holzapfel
Martin Puschmann
Tokusuke Kimura
Fumio Kurosu
Original Assignee
Woelm Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26091956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK97286(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Woelm Pharma Gmbh & Co filed Critical Woelm Pharma Gmbh & Co
Publication of DK97286A publication Critical patent/DK97286A/da
Publication of DK97286D0 publication Critical patent/DK97286D0/da
Publication of DK164023B publication Critical patent/DK164023B/da
Application granted granted Critical
Publication of DK164023C publication Critical patent/DK164023C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK097286A 1984-07-07 1986-03-04 Fremgangsmaade til fremstilling af gammaglobulin, der er egnet til intravenoes indgivelse DK164023C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP84107985 1984-07-07
EP84107985A EP0168506B2 (en) 1984-07-07 1984-07-07 Process for preparing gamma globulin suitable for intravenous administration
EP8500320 1985-07-03
PCT/EP1985/000320 WO1986000530A1 (en) 1984-07-07 1985-07-03 Process for preparing gamma globulin suitable for intravenous administration
JP26362295 1995-09-19
JP7263622A JPH08319241A (ja) 1984-07-07 1995-09-19 静脈注射用ガンマグロブリン組成物

Publications (4)

Publication Number Publication Date
DK97286A true DK97286A (da) 1986-03-04
DK97286D0 DK97286D0 (da) 1986-03-04
DK164023B DK164023B (da) 1992-05-04
DK164023C DK164023C (da) 1992-09-28

Family

ID=26091956

Family Applications (1)

Application Number Title Priority Date Filing Date
DK097286A DK164023C (da) 1984-07-07 1986-03-04 Fremgangsmaade til fremstilling af gammaglobulin, der er egnet til intravenoes indgivelse

Country Status (8)

Country Link
EP (1) EP0168506B2 (da)
JP (2) JPH0816065B2 (da)
AT (1) ATE59144T1 (da)
DE (1) DE3483784D1 (da)
DK (1) DK164023C (da)
FI (1) FI84136C (da)
NO (1) NO168943C (da)
WO (1) WO1986000530A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
EP3088412B1 (en) 2001-03-09 2021-05-05 Chugai Seiyaku Kabushiki Kaisha Protein purification method
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
MX349005B (es) 2011-08-26 2017-07-06 Baxalta Inc Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
JPS5732228A (en) * 1980-08-05 1982-02-20 Green Cross Corp:The Preparation of immunoglobulin usable for intravenous injection
JPS57203017A (en) * 1981-06-09 1982-12-13 Fujirebio Inc Purifying method of immunoglobulin
DE3173666D1 (en) * 1981-10-29 1986-03-13 Green Cross Corp Process for preparing immunoglobulin suitable for intravenous injection

Also Published As

Publication number Publication date
DE3483784D1 (de) 1991-01-31
EP0168506B1 (en) 1990-12-19
FI84136C (fi) 1991-10-25
ATE59144T1 (de) 1991-01-15
EP0168506B2 (en) 1998-01-07
WO1986000530A1 (en) 1986-01-30
FI84136B (fi) 1991-07-15
FI860350L (fi) 1986-01-24
NO168943B (no) 1992-01-13
FI860350A0 (fi) 1986-01-24
NO168943C (no) 1992-04-22
EP0168506A1 (en) 1986-01-22
DK97286D0 (da) 1986-03-04
JPH08319241A (ja) 1996-12-03
DK164023B (da) 1992-05-04
NO860848L (no) 1986-03-06
DK164023C (da) 1992-09-28
JPH0816065B2 (ja) 1996-02-21
JPS61500972A (ja) 1986-05-15

Similar Documents

Publication Publication Date Title
Burnstock et al. P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y-but not the P2x-purinoceptor
SE8402549D0 (sv) Substituerade moranolinderivat
ATE84967T1 (de) Verwendung von pentoxifyllin zur behandlung entzuendlicher erkrankungen.
DK160460C (da) Insulinpraeparat til nasal eller rektal administration og anvendelse af et insulinderivat til fremstilling af praeparatet
TR199700574T1 (xx) Molek�ler �aperon �retiminin haz�rlanmas� i�in yararl� hidroksilamin t�revleri ve bu t�revlerin haz�rlanmas�.
DK0656348T3 (da) Eddikesyrederivater som medikamenter
DK304682A (da) Vandholdigt topisk praeparat og fremgangsmaade til formindskelse af vandtab fra saadanne praeparater
Derechin The assay of human plasminogen with casein as substrate
KR880013572A (ko) 인슐린 및 인슐린 유도체의 혼합결정체, 이의 제조방법, 이를 함유하는 약제 및 이의 용도
FI844557L (fi) Koncentrat av antihemofilfaktorn viii och foerfarande foer framstaellning av detsamma.
Boyland et al. Enzyme activity in relation to cancer: inhibition of urinary β-glucuronidase of patients with cancer of the bladder by oral administration of 1: 4-saccharolactone and related compounds
DK164023C (da) Fremgangsmaade til fremstilling af gammaglobulin, der er egnet til intravenoes indgivelse
ATE59554T1 (de) Auf mercaptoethansulfonsaeuren basierende pharmazeutische zusammensetzungen, organische abkoemmlinge von mercaptoethansulfonsaeuren sowie verfahren zu deren herstellung.
GB1271466A (en) Thiocarbamic acid derivatives
Schumacher et al. Intravascular degranulation of neutrophils: an important factor in inflammation?
GB1526205A (en) Treatment of interferon-like material
KR840002657A (ko) 인터페론 조성물의 제조방법
Welsh et al. Heat-shock treatment of mouse pancreatic islets results in a partial loss of islet cells but no remaining functional impairment among the surviving β cells
Frankl et al. Enzyme activity in the serum and common duct bile of dogs
Foá-Tomasi et al. Enhanced inhibition of RNA synthesis by amanitins in in vitro cultured cells
Lowenthal et al. The inhibition of hyaluronidase by sodium salicylate and its possible metabolites
Mitidieri et al. Effect of salicylate on blood and liver xanthine dehydrogenase of rats
Nellas et al. Pancreatic collagenase therapy for severe, progressive systemic sclerosis: Effect on skin and on hydroxyproline content in urine
Frank Aldose reductase activity and basement membrane thickening
Carstens et al. The soluble, cyclic AMP-stimulated protein kinase catalyses the phosphorylation of different membrane proteins from those which are phosphorylated by the membrane bound enzyme

Legal Events

Date Code Title Description
PBP Patent lapsed